RGC-32 is a novel regulator of the T-lymphocyte cell cycle.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.yexmp.2015.03.011PMID 25770350PMCID PMC5061555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dual role of Response gene to complement-32 in multiple sclerosis.

  2013cited by this paper
• Response gene to complement 32 deficiency causes impaired placental angiogenesis in mice.

  2013cited by this paper
• IL-21 Promotes Lupus-like Disease in Chronic Graft-versus-Host Disease through Both CD4 T Cell- and B Cell-Intrinsic Mechanisms

  2012cited by this paper
• FoxO transcription factors; Regulation by AKT and 14-3-3 proteins.

  2011cited by this paper
• Epigenetic modifications induced by RGC-32 in colon cancer.

  2010cited by this paper
• RGC-32 Mediates Transforming Growth Factor-β-induced Epithelial-Mesenchymal Transition in Human Renal Proximal Tubular Cells*

  2009cited by this paper
• Response gene to complement 32 is required for C5b-9 induced cell cycle activation in endothelial cells.

  2009cited by this paper
• Response Gene to Complement 32, a Novel Hypoxia-Regulated Angiogenic Inhibitor

  2009cited by this paper
• Gene array analysis reveals a common Runx transcriptional programme controlling cell adhesion and survival

  2008cited by this paper
• Complement C5 regulates the expression of insulin-like growth factor binding proteins in chronic experimental allergic encephalomyelitis.

  2008cited by this paper
• Response gene to complement 32 expression is induced by the luteinizing hormone (LH) surge and regulated by LH-induced mediators in the rodent ovary.

  2008cited by this paper
• FoxO transcription factors in the maintenance of cellular homeostasis during aging.

  2008influential reference
• Role of response gene to complement 32 in diseases

  2008cited by this paper
• FOXO transcription factors

  2007cited by this paper
• Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis.

  2007cited by this paper
• Transforming growth factor-beta in cancer and metastasis.

  2006influential reference
• Transforming growth factor-β in cancer and metastasis

  2006influential reference
• C5b-9-induced Endothelial Cell Proliferation and Migration Are Dependent on Akt Inactivation of Forkhead Transcription Factor FOXO1*

  2006cited by this paper
• Distinct gene expression patterns of peripheral blood cells in hyper–IgE syndrome

  2005cited by this paper
• Overexpression of RGC-32 in colon cancer and other tumors.

  2005cited by this paper
• IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells.

  2003cited by this paper
• Forkhead transcription factor FoxO1 transduces insulin‐like growth factor's signal to p27Kip1 in primary skeletal muscle satellite cells

  2003cited by this paper
• RUNX transcription factors as key targets of TGF-β superfamily signaling

  2003cited by this paper
• 11,12-Epoxyeicosatrienoic Acid-induced Inhibition of FOXO Factors Promotes Endothelial Proliferation by Down-Regulating p27Kip1*

  2003cited by this paper
• RUNX transcription factors as key targets of TGF-beta superfamily signaling.

  2003influential reference
• Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma

  2003cited by this paper
• CD28 Costimulation Mediates Down-Regulation of p27kip1 and Cell Cycle Progression by Activation of the PI3K/PKB Signaling Pathway in Primary Human T Cells1

  2002cited by this paper
• RGC-32 Increases p34CDC2 Kinase Activity and Entry of Aortic Smooth Muscle Cells into S-phase*

  2002cited by this paper
• The Forkhead Transcription Factor FoxO Regulates Transcription of p27Kip1 and Bim in Response to IL-21

  2002cited by this paper
• Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines

  2001cited by this paper
• Protein Kinase B Regulates T Lymphocyte Survival, Nuclear Factor κb Activation, and Bcl-XL Levels in Vivo

  2000cited by this paper
• Protein Kinase B Regulates T Lymphocyte Survival, Nuclear Factor ␬ B Activation, and Bcl-x L Levels in Vivo

  2000cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

  1999cited by this paper
• Molecular Cloning and Characterization of RGC-32, a Novel Gene Induced by Complement Activation in Oligodendrocytes*

  1998cited by this paper
• Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent.

  1997cited by this paper
• Binding of phosphatidyl-inositol-3-OH kinase to CD28 is required for T-cell signalling

  1994cited by this paper
• Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling

  1994cited by this paper
• Ligation of CD28 receptor by B7 induces formation of D‐3 phosphoinositides in T lymphocytes independently of T cell receptor/CD3 activation

  1993cited by this paper

• Response Gene to Complement 32 promotes cell proliferation and tamoxifen resistance in breast cancer via elevated FoxM1 expression

  2025cites this paper
• Response gene to complement 32 promotes tumorigenesis by mediating DNA damage repair and inhibits CD8+ T cells infiltration in diffuse large B-cell lymphoma

  2025cites this paper
• Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade

  2024cites this paper
• What we need in colorectal cancer research, and why?

  2024cites this paper
• Multiple sclerosis disease activity, a multi-biomarker score of disease activity and response to treatment in multiple sclerosis

  2024cites this paper
• RGC-32 mediates proinflammatory and profibrotic pathways in immune-mediated kidney disease.

  2024cites this paper
• Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications

  2024cites this paper
• Single-Cell RNA-Sequencing Analyses Identify APLNR, INS-IGF2, RGCC Genes May Be Involved in the Pathogenesis of Systemic Sclerosis Skin

  2024cites this paper
• NFATc1 fosters allergic contact dermatitis responses by enhancing the induction of IL-17-producing CD8 cells.

  2024cites this paper
• Serum RGC-32 in children with systemic lupus erythematosus

  2023cites this paper
• RGC-32 facilitates pancreatic cancer via activating Wnt/β-catenin signaling.

  2023cites this paper
• RGCC Promotes Adipocyte Thermogenesis by Modulating Pgc1α Expression

  2023cites this paper
• Diclofenac Disrupts the Circadian Clock and through Complex Cross-Talks Aggravates Immune-Mediated Liver Injury—A Repeated Dose Study in Minipigs for 28 Days

  2023cites this paper
• RGC-32' dual role in smooth muscle cells and atherogenesis.

  2022cites this paper
• Transcriptomic insight into the hybridization mechanism of the Tambacu, a hybrid from Colossoma macropomum (Tambaqui) and Piaractus mesopotamicus (Pacu).

  2022cites this paper
• Increased Suppressor Activity of Ex Vivo Transformed Regulatory T Cells in Comparison with Unstimulated Cells of the Same Donor

  2022cites this paper
• [Increased suppressor activity of transformed ex vivo regulatory T-cells in comparison with unstimulated cells of the same donor].

  2022cites this paper
• Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes

  2021cites this paper
• RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune Encephalomyelitis

  2021cites this paper
• RGCC balances self‐renewal and neuronal differentiation of neural stem cells in the developing mammalian neocortex

  2021cites this paper
• RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive Astrocytosis

  2021cites this paper
• Multiomic analysis reveals decidual‐specific transcriptional programing of MAIT cells

  2021cites this paper
• Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects Against Pulmonary Fibrosis.

  2021cites this paper
• Immune checkpoint modulation enhances HIV-1 antibody induction

  2020cites this paper
• Response gene to complement 32 expression in macrophages augments paracrine stimulation-mediated colon cancer progression

  2019cites this paper
• Itch attenuates CD4 T‐cell proliferation in mice by limiting WBP2 protein stability

  2019cites this paper
• Hybrid analysis of gene dynamics predicts context-specific expression and offers regulatory insights

  2019cites this paper
• RGC-32 and diseases: the first 20 years

  2019cites this paper
• Response Gene to Complement 32 in Vascular Diseases

  2018cites this paper
• Deacetylase activity-independent transcriptional activation by HDAC2 during TPA-induced HL-60 cell differentiation

  2018cites this paper
• Systematic Analysis of Differential Expression Profile in Rheumatoid Arthritis Chondrocytes Using Next-Generation Sequencing and Bioinformatics Approaches

  2018cites this paper
• Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32

  2018cites this paper
• RGC-32 regulates reactive astrocytosis and extracellular matrix deposition in experimental autoimmune encephalomyelitis

  2018cites this paper
• Response by Cui et al to Letter Regarding Article, "RGC-32 (Response Gene to Complement 32) Deficiency Protects Endothelial Cells From Inflammation and Attenuates Atherosclerosis".

  2018cites this paper
• Phosphorylated SIRT1 as a biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.

  2018cites this paper
• Renal proteomic analysis of RGC-32 knockout mice reveals the potential mechanism of RGC-32 in regulating cell cycle.

  2018cites this paper
• Gene expression analysis of human adipose tissue-derived stem cells during the initial steps of in vitro osteogenesis

  2018cites this paper
• PD-1 Blockade and CD27 Stimulation Activate Distinct Transcriptional Programs That Synergize for CD8+ T-Cell–Driven Antitumor Immunity

  2018cites this paper
• PD-1 blockade and CD27 stimulation activate distinct transcriptional programs that synergize for CD8+ T-cell driven anti-tumor immunity

  2018cites this paper
• Structural and functional characterisation of cyclin dependent kinase 1 containing complexes

  2018cites this paper
• Regulator of Cell Cycle (RGCC) Expression during the Progression of Alzheimer's Disease

  2017cites this paper
• Response Gene to Complement-32 Promotes the Imbalance of Treg/Th17 in Patients with Dilated Cardiomyopathy

  2017cites this paper
• RGC-32 is expressed in the human atherosclerotic arterial wall: Role in C5b-9-induced cell proliferation and migration.

  2016cites this paper
• Insights into Gene Expression of Activated Pathogenic Autoimmune T Cells - Studies in Experimental Multiple Sclerosis-like Model

  2016cites this paper
• The role of complement system in adipose tissue-related inflammation

  2016cites this paper
• RGC-32 Promotes Th17 Cell Differentiation and Enhances Experimental Autoimmune Encephalomyelitis

  2016influential citation
• RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.

  2015cites this paper
• Regulator Of Cell Cycle (Rgcc) Expression During The Progression Regulator Of Cell Cycle (Rgcc) Expression During The Progression Of Alzheimer's Disease Of Alzheimer's Disease

  year unknowncites this paper